FOLH1 and prostate cancer: SPECT/CT studies were undertaken in male SCID/Beige mice bearing DU145-PSMA+ prostate cancer xenografts administered [99mTcO2(DPAn-PSMAt)2]+ and [99mTcO2(DPMEP-PSMAt)2]+.